I like the way it's holding up in this crap market. On my watch list.
<img src=http://www.elitetrader.com/vb/attachment.php?s=&postid=2259574
<img src=http://www.elitetrader.com/vb/attachment.php?s=&postid=2259574
HGSI could pop
- Thread starter CaptainObvious
- Start date
Nice little run up. So far so good. Taking some profit, holding a core position.
<img src=http://www.elitetrader.com/vb/attachment.php?s=&postid=2262733
<img src=http://www.elitetrader.com/vb/attachment.php?s=&postid=2262733
Some nice action going on here.
<img src=http://www.elitetrader.com/vb/attachment.php?s=&postid=2262773
<img src=http://www.elitetrader.com/vb/attachment.php?s=&postid=2262773
Still rockin' with HGSI
<img src=http://www.elitetrader.com/vb/attachment.php?s=&postid=2293220
<img src=http://www.elitetrader.com/vb/attachment.php?s=&postid=2293220
Coiling for the next thrust up.
<img src=http://www.elitetrader.com/vb/attachment.php?s=&postid=2302046
<img src=http://www.elitetrader.com/vb/attachment.php?s=&postid=2302046
I like your thinking on this stock. I might buy some closer to the support level if I can.
Do you have any recommendations on a good buy in point?
Do you have any recommendations on a good buy in point?
I have been in HGSI over 6 years. Kicking myself for not loading up.
Benlysta works, know people who have been taking it over 3 years (involved in 1st trials at JHU).
Personally think that HGSI should not sell, but if they do, it will be for more than the $30 GSK buyout rumor. Guess it would be closer to $45 - $50 given that benlysta alone is $25k/year with probably close to 1 million targeted but expect it will be slow to gain sales due to the cost.
Seems to be the biotech era.
Benlysta works, know people who have been taking it over 3 years (involved in 1st trials at JHU).
Personally think that HGSI should not sell, but if they do, it will be for more than the $30 GSK buyout rumor. Guess it would be closer to $45 - $50 given that benlysta alone is $25k/year with probably close to 1 million targeted but expect it will be slow to gain sales due to the cost.
Seems to be the biotech era.
high prices imo
